Contact information

Lucía Millan Urquijo - Partnerships Manager
14/16 Boulevard Poissonière
Areas of activities
  • Biomarkers
  • Drug development
  • Drug discovery
  • Screening
  • Gene Therapy
  • Cardiovascular diseases and circulatory system
  • Inflammatory diseases
  • Immunology
  • Oncology
  • Bioinformatics
  • Genomics
  • Metabolomics
  • Proteomics

Owkin is a full-stack TechBio company on a mission to understand complex biology and derive new multimodal biomarkers through AI. 

By developing a cutting-edge federated learning framework while simultaneously building the world´s biggest network of hospitals, KOLs and high-quality, multimodal datatest, we are focused on making long-term, transformative improvements to medical research and drug development. 

We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, inmunity and inflammation. 

Products and services

We identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics using AI trained on world-class patient data through privacy-enhancing technologies.  

Areas of interest for future collaborations
  • Oncology
  • Cardiovascular
  • I&I
  • AI
  • Drug Discovery & Development
  • Target indentification and key biomarkers
  • Patient molecular subtyping